Aurobindo Pharma Limited (NSE: AUROPHARMA)
India
· Delayed Price · Currency is INR 1,241.75
+18.05 (1.48%)
Nov 25, 2024, 3:30 PM IST
Aurobindo Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 25, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 721,210 | 637,941 | 303,575 | 391,729 | 516,388 | 242,081 | Upgrade
|
| Market Cap Growth | 58.35% | 110.14% | -22.50% | -24.14% | 113.31% | -47.32% | Upgrade
|
| Enterprise Value | 736,866 | 632,994 | 283,996 | 394,408 | 532,915 | 281,518 | Upgrade
|
| Last Close Price | 1241.75 | 1088.75 | 515.81 | 655.80 | 858.85 | 400.76 | Upgrade
|
| PE Ratio | 20.25 | 20.11 | 15.75 | 14.79 | 9.68 | 8.51 | Upgrade
|
| Forward PE | 16.83 | 17.77 | 12.19 | 12.83 | 14.88 | 7.98 | Upgrade
|
| PS Ratio | 2.39 | 2.20 | 1.22 | 1.67 | 2.08 | 1.05 | Upgrade
|
| PB Ratio | 2.35 | 2.14 | 1.13 | 1.59 | 2.35 | 1.44 | Upgrade
|
| P/TBV Ratio | 3.16 | 2.46 | 1.31 | 1.85 | 2.73 | 1.78 | Upgrade
|
| P/FCF Ratio | - | - | - | 13.22 | 27.31 | 8.07 | Upgrade
|
| P/OCF Ratio | 53.47 | 26.20 | 12.72 | 7.81 | 15.51 | 5.53 | Upgrade
|
| PEG Ratio | 1.06 | 0.78 | 1.63 | 2.09 | 1.35 | 0.60 | Upgrade
|
| EV/Sales Ratio | 2.43 | 2.18 | 1.14 | 1.68 | 2.15 | 1.22 | Upgrade
|
| EV/EBITDA Ratio | 11.43 | 10.98 | 7.81 | 9.15 | 9.88 | 5.86 | Upgrade
|
| EV/EBIT Ratio | 14.84 | 14.41 | 11.31 | 11.93 | 11.97 | 7.14 | Upgrade
|
| EV/FCF Ratio | -148.80 | - | - | 13.31 | 28.18 | 9.39 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.22 | 0.20 | 0.12 | 0.24 | 0.35 | Upgrade
|
| Debt / EBITDA Ratio | 1.30 | 1.14 | 1.43 | 0.65 | 0.97 | 1.21 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.96 | 2.82 | 1.98 | Upgrade
|
| Asset Turnover | 0.66 | 0.68 | 0.67 | 0.69 | 0.79 | 0.83 | Upgrade
|
| Inventory Turnover | 1.31 | 1.42 | 1.45 | 1.26 | 1.22 | 1.34 | Upgrade
|
| Quick Ratio | 0.85 | 0.96 | 0.98 | 1.10 | 0.90 | 0.67 | Upgrade
|
| Current Ratio | 1.83 | 1.98 | 1.87 | 2.22 | 1.86 | 1.44 | Upgrade
|
| Return on Equity (ROE) | 12.13% | 11.18% | 7.50% | 11.38% | 27.53% | 18.52% | Upgrade
|
| Return on Assets (ROA) | 6.77% | 6.46% | 4.25% | 6.10% | 8.87% | 8.89% | Upgrade
|
| Return on Capital (ROIC) | 8.39% | 8.00% | 5.27% | 7.56% | 11.13% | 11.29% | Upgrade
|
| Earnings Yield | 4.94% | 4.97% | 6.35% | 6.76% | 10.33% | 11.75% | Upgrade
|
| FCF Yield | -0.69% | -0.54% | -0.06% | 7.57% | 3.66% | 12.39% | Upgrade
|
| Dividend Yield | 0.25% | 0.41% | 0.58% | 1.37% | 0.47% | 0.75% | Upgrade
|
| Payout Ratio | 7.38% | 8.31% | 22.80% | 9.96% | 4.39% | 6.17% | Upgrade
|
| Buyback Yield / Dilution | 0.49% | - | - | - | - | -0.00% | Upgrade
|
| Total Shareholder Return | 0.74% | 0.41% | 0.58% | 1.37% | 0.47% | 0.75% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.